Navigation Links
Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
Date:4/16/2008

Results presented at American Association for Cancer Research meeting

indicate that technology could improve control in administration of

non-water-soluble drugs to treat cancer and possibly other diseases

PRINCETON, N.J., April 16 /PRNewswire/ -- Celator Pharmaceuticals today reported results on a novel approach designed to deliver drugs that are incapable of dissolving in water (hydrophobic drugs) in nanoparticles to enhance and control drug circulation. These findings allow the company to combine hydrophobic drugs such as paclitaxel with other anti-cancer drugs, based on the company's proprietary CombiPlex technology(TM). The results were presented today in a poster presentation at the American Association for Cancer Research meeting in San Diego.

CombiPlex(TM) is a drug ratio technology platform that represents a new approach which identifies a ratio of drugs that will deliver a synergistic benefit, locks the desired ratio in a drug delivery vehicle, and maintains the ratio in patients with the goal of improving clinical outcomes.

To date, Celator has utilized liposomes to deliver synergistic drug combinations to treat cancer. Hydrophobic drugs such as paclitaxel are not amenable to this form of delivery because they detach from liposomes almost immediately after injection. Celator scientists reported that they were able to generate a library of hydrophobic paclitaxel conjugates incorporated into nanoparticles. In preclinical testing, these nanoparticles were shown to circulate in the blood for more than 24 hours, allowing the drug to accumulate selectively in solid tumors where it can then be released and exposed to the tumor cells.

According to the research findings, the ability to optimize paclitaxel conjugates could make it possible for higher drug levels to be maintained in plasma for extended periods, which is associated with superior preclinical antitumor efficacy when compared to drug delivery involving pacli
'/>"/>

SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 2015 UNICANCER pourra ... pouvant bénéficier de l,innovation thérapeutique.   ... de contenu pour l,Entreprise, annonce que sa solution ... Centres de lutte contre le cancer (CLCC), comme ... ConSoRe (Continuum Soin-Recherche) conduit par la société de ...
(Date:3/5/2015)... , March 5, 2015 Vermillion, ... solutions company focused on gynecologic disease, announced today ... results before the market open on Wednesday, March ... and webcast at 8:30am Eastern. Conference Call & ... at 8:30am Eastern/5:30am Pacific Domestic: , 800-753-9057International: , ...
(Date:3/5/2015)... March 5, 2015  BioPhotas, Inc., an FDA registered ... patented photo-therapeutic technologies to treat skin, muscle and joint ... Semper Fi Fund to provide BioPhotas, flagship product, the ... pain management solutions.  Commenting on the ... who used the Celluma at the Warrior Hope and ...
Breaking Medicine Technology:TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 2TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 3TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 4Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3
... Medical, Inc. (NASDAQ: ICUI ) today announced ... 36th annual meeting of the California Society of Health-System ... company,s ChemoClave® closed system transfer device (CSTD) designed to ... to hazardous drugs is more affordable for hospitals to ...
... FRANCISCO and RIDGEFIELD, Conn., Nov. 8, 2011  Boehringer ... Phase 2 studies evaluating the combination of the company,s ... ribavirin (RBV) in treatment-naive genotype-1 (GT1) hepatitis C virus ... SILEN-C1 studies show that BI 201335 may have ...
Cached Medicine Technology:Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 2Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 3Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 4Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types 2Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types 3Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types 4Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types 5
(Date:3/6/2015)... (PRWEB) March 06, 2015 Mediaplanet today ... Health,” a campaign that seeks to educate, encourage, and ... it comes to their health and their health care ... it has never been more pertinent to prioritize well-woman ... , The print component of “Women’s Health” is distributed ...
(Date:3/6/2015)... March 06, 2015 “ Pokemini ” was ... features the latest and coolest mobile applications on the iOS, ... and host of NewsWatch, conducted the app review and shared ... , Over the last couple of years, mobile games ... the game. For example, Candy Crush allows users to connect ...
(Date:3/6/2015)... Ticket Down is a reputable source for authentic Garth ... After being away from the touring business for so ... letting up on his “Garth Brooks World Tour.” The tour ... to venues around the United States. The duo recently announced ... the Moda Center in Portland, OR. The husband and wife ...
(Date:3/6/2015)... 06, 2015 As the Muscular Dystrophy ... programs, the organization has hired two new Scientific Program ... They will report to Grace Pavlath, Ph.D, who joined ... Scientific Program Director, and together will lead MDA as ... and cures for various types of neuromuscular and motor ...
(Date:3/6/2015)... 06, 2015 US Sports Football Camps ... camps – two non-contact specialty camps and one contact ... Perfect Performance Training, located at Bowie State University and ... position specific skills, speed and strength of football athletes. ... University with Marvin Graves, former quarterback in the Canadian ...
Breaking Medicine News(10 mins):Health News:The Well-Woman: Encouraging Regular Screenings and Advocating for Women’s Health Rights with Mediaplanet’s “Women’s Health” Campaign 2Health News:A Kawaii Social Game was Featured on NewsWatch Television on February 26, 2015 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:US Sports Camps to Host Three New Football Camps in Maryland 2
... toxins, or too much/too little of the active ingredient ... companies market them, men continue to buy them and ... drugs for erectile dysfunction. , A new study, conducted ... the American Urological Association annual meeting in San Francisco, ...
... in CMAJ ( Canadian Medical Association Journal ) found a ... women using antidepressants (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091208.pdf . ... 3.7% of women will use them at some point during ... relapse which can put mother and baby at risk. ...
... IPNC Salmon ... cuisines from around the United States. , ... (PRWEB) May 31, 2010 -- Long-time guest chef and board member of Oregon’s ... Northwest region at a June 8 White House Picnic for 2000 people. The Picnic will ...
... ... his patients who claimed to have near-death experiences as a result of their heart attack. ... irresponsible of him to ignore the evidence of these stories? , ... (PRWEB) May 31, 2010 -- CONSCIOUSNESS BEYOND LIFE (June ...
... two per cent of cesarean births in British Columbia were ... and assisted vaginal deliveries varied widely across health regions in ... Columbia researchers. "There is a misconception that the overall ... says lead author Gillian Hanley, a PhD student in the ...
... is known about anticancer benefits of supplements, researchers caution , ... vitamins may do nothing to protect men against bladder cancer ... cancer. , In one study examining vitamin use, researchers analyzed ... took part in prostate screenings. , More than 60 ...
Cached Medicine News:Health News:Dangers Lurk in Impotence Drugs Sold on Web 2Health News:Antidepressants in pregnancy increase risk of miscarriage 2Health News:International Pinot Noir Celebration Guest Chef Jason Stoller Smith to Cook Famed Northwest Salmon Bake at White House Picnic 2Health News:CONSCIOUSNESS BEYOND LIFE by World Renowned Cardiologist, Pim Van Lommel Reveals Scientific Argument for Near-Death Experiences 2Health News:Regional differences in C-section rate not a result of maternal request: UBC study 2Health News:Vitamins Fail to Protect Men Against Bladder Cancer 2
... were developed to assist in the tracking ... use of existing capital equipment, minimize lost ... of their employees, organizations are seeking ways ... assets and ensure those assets remain in ...
Radianse indoor positioning supports healthcare asset management with a way to locate medical equipment, devices and other portable assets....
Agility can facilitate bed and room management through business process optimization using RFID technology. Bed and room management may be integrated with other AgileTrac products....
... Agility can provide RFID-enabled ... consumables, including medical and surgical ... receiving process, track tote deliveries ... well as track and manage ...
Medicine Products: